Market News AIOpen the app

ADCT stock news · ADC Therapeutics SA

Stories about ADC Therapeutics SA (ADCT) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for ADCT

Follow ADC Therapeutics SA (ADCT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ADCT
Free on the App Store and Google Play, or on the web.
  1. Nov 3, 2026, 3:15 AM ET · Deal

    ADC Therapeutics is giving a new employee the chance to buy 17,000 shares.

    Neutral

    ADC Therapeutics granted options to buy 17,000 shares to a new employee. This routine hiring step may add shares if used, but gives no reason to change the company's outlook.

  2. Aug 13, 2026, 9:15 AM ET · Results

    Transcript of ADC Therapeutics' earnings call for Q2 2026 released.

    Good for ADCT

    ADC Therapeutics' Q2 2026 earnings call revealed a slight increase in revenues and a strategic reorganization aimed at enhancing the commercialization of its therapies. The completion of LOTIS 7 enrollment and ongoing regulatory efforts for Zynlonta/glofitamab position the company favorably in the DLBCL market, suggesting potential for future growth.